After a few rough days, has the stock market bottomed? Bob Doll seems to be leaning towards “yes”. “There is a chance the bottom’s in. I’m not going to say…
Author: Validea
Doll Weighs In On Rate Hikes, And Whether We've Bottomed
After a few rough days, has the stock market bottomed? Bob Doll seems to be leaning towards “yes”. “There is a chance the bottom’s in. I’m not going to say…
The Search For The Silver Value Metric Bullet
Is there a single, silver bullet valuation metric that you can use to accurately evaluate any stock in the market? An interesting recent piece from Barron’s looks at a couple…
Doubleline's Baha: Don't Think Short Duration Bonds Are A Rate-Hike Panacea
Conventional wisdom seems to be that the best way to deal with looming interest rate hikes is by buying only short duration bonds, or dumping bonds altogether. But in a…
Doubleline's Baha: Don't Think Short Duration Bonds Are A Rate-Hike Panacea
Conventional wisdom seems to be that the best way to deal with looming interest rate hikes is by buying only short duration bonds, or dumping bonds altogether. But in a…
El-Erian: "Classic Overshoot" In EMs Will Hurt Now, Create Opportunities Later
Mohamed El-Erian says we are seeing a “classic overshoot” to the downside in emerging markets right now, which should lead to more pain in the near term but opportunity over…
El-Erian: "Classic Overshoot" In EMs Will Hurt Now, Create Opportunities Later
Mohamed El-Erian says we are seeing a “classic overshoot” to the downside in emerging markets right now, which should lead to more pain in the near term but opportunity over…
Oberweis: With Biotech Pricey, Try Other Healthcare Options
Many biotech stocks have had exceptional runs over the past few years. But newsletter guru Jim Oberweis says that has led to some exorbitant valuations, and he says there are…
Why PCP -- And Other Industrials -- Are Buffett's Kind Of Stocks
Warren Buffett made headlines recently with Berkshire Hathaway’s acquisition of Precision Castparts. And in his latest Forbes.com column, Validea CEO John Reese talks about why the firm is a “Buffett-esque”…
Why PCP -- And Other Industrials -- Are Buffett's Kind Of Stocks
Warren Buffett made headlines recently with Berkshire Hathaway’s acquisition of Precision Castparts. And in his latest Forbes.com column, Validea CEO John Reese talks about why the firm is a “Buffett-esque”…